Back to results
US 2026/0062733 A1Published application
Test method for mild cognitive impairment, test reagent for mild cognitive impairment, and method for screening therapeutic candidate substances for mild cognitive impairment
AssigneeBioradical Research Institute Corp.
InventorsMasaichi Lee, Tomoko Komatsu
Life of this patent
Estimating the term…
Abstract
Provided is a test method with which mild cognitive impairment (MCI) is detectable and a measurement reagent for use in the test method. A test method for MCI according to the present invention includes a step of measuring the activity of superoxide dismutase (SOD) in a biological sample of a subject.
Claims5
1-10. (canceled)
A method for screening therapeutic candidate substances for MCI, the method comprising a step of selecting, as a therapeutic candidate substance for MCI, an activating substance that enhances activity of SOD from test substances.
14-15. (canceled)
Dependencies are inferred from the claim text.